Benign Prostatic Hyperplasia
Abstract
No AccessJournal of UrologyAdult urology1 Apr 2007Benign Prostatic Hyperplasia Steven A. KaplanM.D. Steven A. KaplanSteven A. Kaplan More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2006.12.023AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Pre-Clinical Evidence for the Use of Phosphodiesterase-5 Inhibitors for Treating Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms 1 : Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial. JAMA2006; 296: 2319. Google Scholar 2 : Combination of an alpha blocker, alfuzosin SR and a PDE-5 inhibitor, sildenafil citrate is superior to monotherapy in treating lower urinary tract symptoms (LUTS) and sexual dysfunction. J Urol2006; 175: 527. abstract 1638. Google Scholar 3 : The efficacy and safety of tadalafil administered once a day for lower urinary tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH). J Urol2006; 175: 527. abstract 1636. Google Scholar 4 : Sildenafil improves erectile function and urinary symptoms in men with erectile dysfunction and concomitant lower urinary tract symptoms. J Urol2006; 175: 527. abstract 1637. Link, Google Scholar © 2007 by American Urological AssociationFiguresReferencesRelatedDetails Volume 177Issue 4April 2007Page: 1430-1433 Advertisement Copyright & Permissions© 2007 by American…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design.
Read the paper
Related studies
- Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
- The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
- Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
- Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study
- Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
- Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.